Retrieve available abstracts of 190 articles: HTML format
Single Articles
July 2025
TSUKIOKI T, Takata N, Dennis SR, Terata K, et al Japanese translation of the Functional Assessment of Cancer Therapy-Breast + 4
(FACT-B + 4) following international guidelines: a verification of linguistic
validity.
Breast Cancer. 2025;32:773-782. PubMedAbstract available
SOWA Y, Seki H, Abe H, Komiya T, et al Influence of age on patient decision regret following breast reconstruction: a
multicenter collaborative study in Japan.
Breast Cancer. 2025;32:826-833. PubMedAbstract available
HARA Y, Tan PH, Foschini MP, Yano H, et al Polymorphous adenocarcinoma-like tumor of the breast: the first case report from
Japan.
Breast Cancer. 2025;32:867-873. PubMedAbstract available
TAKANO Y, Mizuno K, Iwase M, Morita S, et al Tumor mutational burden status and clinical characteristics of invasive lobular
carcinoma of the breast.
Breast Cancer. 2025;32:816-825. PubMedAbstract available
June 2025
KUL KOPRULU T, Aras S, Erkal Cam B, Kara A, et al Comparison of transcriptome profiles of radiotherapy beams on MCF-7 breast cancer
xenografts.
Breast Cancer. 2025 Jun 27. doi: 10.1007/s12282-025-01735. PubMedAbstract available
HUANG M, Zhang J, Yan C, Ling R, et al KLF13 promotes breast cancer progression through the HTRA1 and the Hedgehog
signaling pathway.
Breast Cancer. 2025 Jun 24. doi: 10.1007/s12282-025-01737. PubMedAbstract available
YOSHINAMI T, Takano Y, Ozaki Y, Kajiwara Y, et al Correction: Real?world evidence from Japan regarding survival outcomes and
treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy
as first? or second?line treatment for hormone receptor-positive, HER2?negative
advanced or met
Breast Cancer. 2025 Jun 23. doi: 10.1007/s12282-025-01736. PubMed
SANLI AN, Turan B, Tekcan Sanli DE, Aydogan F, et al Marital status as an independent prognostic factor in male breast cancer: a
SEER-based cohort study.
Breast Cancer. 2025 Jun 16. doi: 10.1007/s12282-025-01733. PubMedAbstract available
LUO Y, Saibaidula Y, Sun Y, Ye Y, et al Treatment and prognosis of patients with hormone receptor-low positive (1%-10%)
breast cancer: a retrospective propensity score-matched analysis.
Breast Cancer. 2025 Jun 9. doi: 10.1007/s12282-025-01730. PubMedAbstract available
AKITA Y, Velaga R, Iwase M, Shimada S, et al Correction to: Prognostic impact of ER?staining patterns and heterogeneity of ER
positive HER2 negative breast cancer.
Breast Cancer. 2025 Jun 9. doi: 10.1007/s12282-025-01729. PubMed
ISHITOBI M, Yoshida A, Kimura Y, Sagara Y, et al Impact of margin status on ipsilateral breast tumor recurrence after
breast-conserving treatment for patients with breast cancer who received
neoadjuvant chemotherapy: a retrospective multi-institutional study of 1813
cases.
Breast Cancer. 2025 Jun 9. doi: 10.1007/s12282-025-01732. PubMedAbstract available
TURNA M, Yildirim BA, Numanoglu C, Gul ME, et al Stereotactic radiosurgery for HER2-positive breast cancer brain metastases:
prognostic factors and the evolving role of anti-HER2 therapies.
Breast Cancer. 2025 Jun 8. doi: 10.1007/s12282-025-01731. PubMedAbstract available
XU G, Zhao K, Zhou X, Zhang L, et al Clinical application of 90-gene expression test in a patient with occult breast
cancer: a case report and literature review.
Breast Cancer. 2025 Jun 5. doi: 10.1007/s12282-025-01728. PubMedAbstract available
PENG G, Lee G, Kim S, Chen QY, et al Meta-analysis of smoking and breast cancer risk: by age of smoking initiation.
Breast Cancer. 2025 Jun 3. doi: 10.1007/s12282-025-01715. PubMedAbstract available
May 2025
SHIEN T, Nogi H, Ogiya A, Ishitobi M, et al Immediate breast reconstruction surgery for breast cancer: current status and
future directions.
Breast Cancer. 2025 May 26. doi: 10.1007/s12282-025-01723. PubMedAbstract available
IMOTO S, Yasojima H, Nagashima T, Onishi T, et al Axillary surgery in patients with breast cancer with one to three positive micro-
or macrometastases in the sentinel lymph nodes: an observational study.
Breast Cancer. 2025 May 25. doi: 10.1007/s12282-025-01726. PubMedAbstract available
ISOGAI A, Terada M, Wanifuchi-Endo Y, Fujita T, et al Optimal patient population for adjuvant S-1 therapy in hormone receptor-positive,
HER2-negative early breast cancer.
Breast Cancer. 2025 May 24. doi: 10.1007/s12282-025-01722. PubMedAbstract available
COOPER J, Airstone B, Beaman E, Carollo E, et al Helix pomatia agglutinin bound to surface glycans of small extracellular vesicles
in-vitro and in-vivo increases in early and late stage breast cancer.
Breast Cancer. 2025 May 24. doi: 10.1007/s12282-025-01724. PubMedAbstract available
FUSHIMI A, Terada M, Tahara R, Nakazawa Y, et al Assessing the quality of Japanese online breast cancer treatment information
using large language models: a comparison of ChatGPT, Claude, and expert
evaluations.
Breast Cancer. 2025 May 21. doi: 10.1007/s12282-025-01719. PubMedAbstract available
YOSHINAMI T, Takano Y, Ozaki Y, Kajiwara Y, et al Real-world evidence from Japan regarding survival outcomes and treatment sequence
in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or
second-line treatment for hormone receptor-positive, HER2-negative advanced or
metastatic brea
Breast Cancer. 2025 May 20. doi: 10.1007/s12282-025-01713. PubMedAbstract available
YOSHINAMI T, Shibata N, Tamaki K, Ishimaru K, et al Real-world evidence of febrile neutropenia-related hospitalization on patients
with perioperative chemotherapy for early breast cancer in Japan.
Breast Cancer. 2025 May 19. doi: 10.1007/s12282-025-01714. PubMedAbstract available
AKITA Y, Velaga R, Iwase M, Shimada S, et al Prognostici of ER-staining patterns and heterogeneity of ER positive HER2
negative breast cancer.
Breast Cancer. 2025 May 18. doi: 10.1007/s12282-025-01716. PubMedAbstract available
LIU W, Gao F, Ma N, Zhang H, et al Effects of CBT-based interventions on health outcomes in breast cancer patients:
a systematic review and Meta-analysis.
Breast Cancer. 2025 May 14. doi: 10.1007/s12282-025-01711. PubMedAbstract available
USHIGUSA T, Hirakawa N, Kanomata N Reevaluating HER2-null breast cancer using an enhanced HER2 immunohistochemistry
protocol.
Breast Cancer. 2025 May 13. doi: 10.1007/s12282-025-01721. PubMedAbstract available
MIYASHITA M, Kumamaru H, Hayashi N, Kimura F, et al Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends
in Japan.
Breast Cancer. 2025 May 12. doi: 10.1007/s12282-025-01718. PubMedAbstract available
TAGUCHI M, Takada M, Jiaxi H, Fukui Y, et al Detection capability of the Medical Imaging Projection System for sentinel lymph
node biopsy in patients with breast cancer with and without neoadjuvant
chemotherapy: a retrospective study.
Breast Cancer. 2025 May 10. doi: 10.1007/s12282-025-01712. PubMedAbstract available
LU ZZ, Guo LF, Zhou J, Wu SG, et al A nomogram to predict the benefit of postmastectomy radiotherapy in breast cancer
with nodal micrometastases.
Breast Cancer. 2025 May 7. doi: 10.1007/s12282-025-01717. PubMedAbstract available
KAKIMI K, Sugie T Why combine and why neoadjuvant? Tumor immunological perspectives on
chemoimmunotherapy in triple-negative breast cancer.
Breast Cancer. 2025 May 6. doi: 10.1007/s12282-025-01707. PubMedAbstract available
VENKATARAMAN J, Mokbel K Limitations in translating in vitro ADSC findings to clinical breast cancer risk.
Breast Cancer. 2025 May 5. doi: 10.1007/s12282-025-01710. PubMed
TAKAHASHI M, Minoura Y, Den H, Nomizu T, et al Analysis of the conditions for applying BRCA genetic testing to women with breast
cancer using the Japanese HBOC consortium and the Japanese organization of
hereditary breast and ovarian cancer (JOHBOC) registry project database.
Breast Cancer. 2025 May 5. doi: 10.1007/s12282-025-01704. PubMedAbstract available
SOEDA I, Shibata M, Inaishi T, Ichikawa T, et al ATPase copper transporting beta attenuates malignant features with high
expression as an indicator of favorable prognosis in breast cancer.
Breast Cancer. 2025 May 2. doi: 10.1007/s12282-025-01705. PubMedAbstract available
LAM MC, Grufman V, Fertsch S, Recker F, et al Effects of breast size on breast reconstruction in BRCA mutation carriers and
genetic high-risk patients after bilateral mastectomy.
Breast Cancer. 2025;32:582-595. PubMedAbstract available
WU Q, He J, Herrler T, Yu B, et al Adipose-derived stem cells enhance the tumorigenic potential of pre-malignant
breast epithelial cells through paracrine activation of PI3K-AKT pathway.
Breast Cancer. 2025;32:552-565. PubMedAbstract available
MATSUBARA Y, Suganuma N, Nakamoto S, Kikawa Y, et al Repeated sentinel lymph node biopsy for local recurrence after breast-conserving
surgery.
Breast Cancer. 2025;32:512-519. PubMedAbstract available
April 2025
KONISHI T, Kumamaru H, Niikura N, Sagara Y, et al Annual report of National Clinical Database-Breast Cancer Registry in 2021:
characteristics categorized by body mass index and menopause status.
Breast Cancer. 2025 Apr 21. doi: 10.1007/s12282-025-01698. PubMedAbstract available
USHIGUSA T, Yoshida A, Kanomata N Reply to the letter to the editor "Pembrolizumab added to neoadjuvant
chemotherapy may improve pathological complete response in androgen-receptor
positive and low tumor-infiltrating lymphocytes triple-negative breast cancer
patients".
Breast Cancer. 2025 Apr 13. doi: 10.1007/s12282-025-01703. PubMed
DING X, Zhu M, Kan H, Wang Q, et al Relationship between psychological resilience and cognitive function on breast
cancer chemotherapy patients: a person-centered method.
Breast Cancer. 2025 Apr 10. doi: 10.1007/s12282-025-01697. PubMedAbstract available
JO A, Iwamoto T, Suzuki Y, Ogata R, et al Validation of the Symptom Illustration Scale within an electronic
Patient-Reported Outcomes Monitoring environment for metastatic breast cancer
patients undergoing chemotherapy.
Breast Cancer. 2025 Apr 10. doi: 10.1007/s12282-025-01702. PubMedAbstract available
WATANUKI R, Sakai H, Takehara Y, Yoshida A, et al Risk factors for early recurrence in patients with hormone receptor-positive,
HER2-negative breast cancer: a retrospective cohort study in Japan (WJOG15721B).
Breast Cancer. 2025 Apr 10. doi: 10.1007/s12282-025-01700. PubMedAbstract available
MIZUTA M, Okumura M, Inoue J, Ueda Y, et al Association between preoperative grip strength and postoperative upper extremity
impairments in patients with breast cancer: a retrospective cohort study.
Breast Cancer. 2025 Apr 10. doi: 10.1007/s12282-025-01699. PubMedAbstract available
NAGAI SE, Hattori M, Yoshinami T, Masuda H, et al Overall survival of palbociclib plus endocrine therapy in Japanese patients with
HR+/HER2- advanced breast cancer in the first-or second-line setting: a
multicenter observational study (P-BRIDGE study).
Breast Cancer. 2025 Apr 5. doi: 10.1007/s12282-025-01689. PubMedAbstract available
MAN V, Duan J, Luk WP, Fung LH, et al Different strategies in de-escalation of axillary surgery in node-positive breast
cancer following neoadjuvant treatment: a systematic review and meta-analysis of
long-term outcomes.
Breast Cancer. 2025 Apr 5. doi: 10.1007/s12282-025-01692. PubMedAbstract available
SONG N, Yang K, Li Y Constructing shared genetic architecture between bioavailable testosterone and
luminal A breast cancer in female.
Breast Cancer. 2025 Apr 3. doi: 10.1007/s12282-025-01696. PubMedAbstract available
UEMATSU M, Nakajima H, Miyake H, Wakabayashi M, et al Digitally quantified area of residual tumor after neoadjuvant chemotherapy in
HER2-positive breast cancer.
Breast Cancer. 2025 Apr 2. doi: 10.1007/s12282-025-01694. PubMedAbstract available
March 2025
GARCIA-CHICO C, Lopez-Ortiz S, Lorenzo-Crespo C, Pinto-Fraga J, et al Wrapping up the evidence: bandaging in breast cancer-related lymphedema-a
systematic review and meta-analysis.
Breast Cancer. 2025 Mar 31. doi: 10.1007/s12282-025-01693. PubMedAbstract available
TOI M Capecitabine with aromatase inhibitors in the front-line therapy for metastatic
breast cancer.
Breast Cancer. 2025 Mar 27. doi: 10.1007/s12282-025-01695. PubMed
SOTA Y, Seno S, Naoi Y, Honma K, et al IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts
response to neoadjuvant chemotherapy: new validation analyses.
Breast Cancer. 2025 Mar 24. doi: 10.1007/s12282-025-01687. PubMedAbstract available
WANG SJ, Feng X, Zhang W, Fang H, et al Specific types of anxiety regarding radiation therapy in patients with breast
cancer: a longitudinal study.
Breast Cancer. 2025 Mar 23. doi: 10.1007/s12282-025-01690. PubMedAbstract available
USHIGUSA T, Hirakawa N, Kajiura Y, Yoshida A, et al Correction: Clinicopathological significance of androgen receptor expression and
tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective
cohort study.
Breast Cancer. 2025 Mar 17. doi: 10.1007/s12282-025-01688. PubMed
DONG C, Sun Y, Xu X, Li H, et al c-Myc knockdown restores tamoxifen sensitivity in triple-negative breast cancer
by reactivating the expression of ERalpha: the central role of miR-152 and miR-148a.
Breast Cancer. 2025 Mar 3. doi: 10.1007/s12282-025-01683. PubMedAbstract available
SATO K, Fuchikami H, Takeda N, Natsume N, et al Long-term local control and cosmesis of perioperative interstitial brachytherapy
for partial breast irradiation following breast-conserving surgery.
Breast Cancer. 2025;32:447-455. PubMedAbstract available
FARHAT J, Sakai H, Tsurutani J Management of nausea and vomiting induced by antibody-drug conjugates.
Breast Cancer. 2025;32:278-285. PubMedAbstract available
NAKATSUKA K, Karakawa R, Yano T Color differences of skin paddles using the free flap for autologous breast
reconstruction in Asian patients.
Breast Cancer. 2025;32:306-313. PubMedAbstract available
February 2025
WU SI, Chen VC, Hsu YH, Tzang BS, et al Contemporaneous changes in cytokines and cognitive function during chemotherapy
in patients with breast cancer: a prospective follow-up study.
Breast Cancer. 2025 Feb 25. doi: 10.1007/s12282-025-01668. PubMedAbstract available
NATORI K, Igeta M, Morimoto T, Nagahashi M, et al Development and internal validation of a predictive model of overall and
progression-free survival in eribulin-treated patients with breast cancer based
on baseline peripheral blood parameters.
Breast Cancer. 2025 Feb 20. doi: 10.1007/s12282-025-01678. PubMedAbstract available
ANDO Y, Masuda T, Hayashi N, Kosai K, et al SET-binding protein 1 (SETBP1) suppresses cell proliferation in estrogen
receptor-positive breast cancer.
Breast Cancer. 2025 Feb 20. doi: 10.1007/s12282-025-01667. PubMedAbstract available
KAWASHIMA K, Narui K, Nishikawa A, Sasamoto M, et al The impact of axillary lymph-node dissection omission on adjuvant abemaciclib
eligibility in HR-positive, HER2-negative breast cancer with positive sentinel
lymph nodes.
Breast Cancer. 2025 Feb 20. doi: 10.1007/s12282-025-01684. PubMedAbstract available
KIM SH, Oh JM, Kim YJ, Kim J, et al Postoperative cholesterol changes as early predictors of breast cancer-related
lymphedema: a retrospective cohort study.
Breast Cancer. 2025 Feb 18. doi: 10.1007/s12282-025-01682. PubMedAbstract available
NISHIMURA R, Sagara Y, Mitsueda R, Taira T, et al A novel formula to improve the accuracy and prognostic ability of determining the
survival time after recurrent breast cancer.
Breast Cancer. 2025 Feb 18. doi: 10.1007/s12282-025-01677. PubMedAbstract available
RIZK M, Mokbel K Refining the role of surgery in de novo stage IV breast cancer: the need for
biomarkers and mechanistic insights.
Breast Cancer. 2025 Feb 17. doi: 10.1007/s12282-025-01681. PubMed
NAKAYAMA S, Iwamoto T, Araki K, Narui K, et al A prospective cohort study of abemaciclib-induced interstitial lung disease in
metastatic breast cancer after chemotherapy.
Breast Cancer. 2025 Feb 10. doi: 10.1007/s12282-025-01680. PubMedAbstract available
HARA A, Ozaki A, Murakami M, Saito H, et al Breast cancer screening rates and influencing factors among LGBTQ groups in
Japan.
Breast Cancer. 2025 Feb 8. doi: 10.1007/s12282-025-01669. PubMedAbstract available
NAGAHASHI M, Kumamaru H, Kinukawa N, Iwamoto T, et al Breast cancer statistics for Japan in 2022: annual report of the national
clinical database-breast cancer registry-clinical implications including
chemosensitivity of breast cancer with low estrogen receptor expression.
Breast Cancer. 2025 Feb 6. doi: 10.1007/s12282-025-01671. PubMedAbstract available
TOKUNAGA E, Koi Y, Tajiri W, Koga C, et al The impact of breast surgery and systemic therapy on the survival of patients
with de novo stage IV breast cancer.
Breast Cancer. 2025 Feb 2. doi: 10.1007/s12282-025-01675. PubMedAbstract available
January 2025
ONDER T, Karacin C NELBI score: a new clinical calculator of thirty-day mortality following systemic
anticancer therapy in breast cancer patients near the end of life.
Breast Cancer. 2025 Jan 31. doi: 10.1007/s12282-025-01676. PubMedAbstract available
PARK MS, Cho EH, Youn Y, Do IG, et al Importance of circulating tumor DNA analysis at diagnosis in early
triple-negative breast cancer patients.
Breast Cancer. 2025 Jan 31. doi: 10.1007/s12282-025-01673. PubMedAbstract available
ALTUNDAG K Pembrolizumab added to neoadjuvant chemotherapy may improve pathological complete
response in androgen-receptor positive and low tumor-infiltrating lymphocytes
triple-negative breast cancer patients.
Breast Cancer. 2025 Jan 29. doi: 10.1007/s12282-025-01672. PubMed
NAGAHASHI M, Ishikawa E, Nagai T, Kanaoka H, et al Clinical utility of tumor-infiltrating lymphocyte evaluation by two different
methods in breast cancer patients treated with neoadjuvant chemotherapy.
Breast Cancer. 2025 Jan 14. doi: 10.1007/s12282-025-01665. PubMedAbstract available
IWABUCHI E, Miki Y, Xu J, Kanai A, et al Tetraspanins CD63 and CD81 as potential prognostic biomarkers in breast cancer.
Breast Cancer. 2025 Jan 14. doi: 10.1007/s12282-025-01666. PubMedAbstract available
NAKAMURA A, Ohnuki K, Takahashi H, Usami S, et al Impact of breast size and composition on the accuracy of mammography and
ultrasonography in breast cancer screening.
Breast Cancer. 2025 Jan 2. doi: 10.1007/s12282-024-01664. PubMedAbstract available
TAKAHASHI K, Kagami Y, Yoshimura R, Morota M, et al Prospective study of once-daily accelerated partial breast irradiation using
3-dimensional conformal external beam radiotherapy for Japanese women: 12-year
outcomes, toxicity, and cosmesis.
Breast Cancer. 2025;32:197-207. PubMedAbstract available
NAKAYAMA S, Yoshizawa A, Tsurutani J, Yoshimura K, et al Real-world incidence of and risk factors for abemaciclib-induced interstitial
lung disease in Japan: a nested case-control study of abemaciclib-induced
interstitial lung disease (NOSIDE).
Breast Cancer. 2025;32:177-185. PubMedAbstract available
SUNG YN, Jeon T, Lee JY, Oh J, et al Comprehensive characterization of invasive mammary carcinoma with lobular
features: integrating morphology and E-cadherin immunohistochemistry patterns.
Breast Cancer. 2025;32:186-196. PubMedAbstract available
BEHRENS AS, Huebner H, Haberle L, Stamminger M, et al Comparative assessment of breast volume using a smartphone device versus MRI.
Breast Cancer. 2025;32:166-176. PubMedAbstract available
GARG S, Rai G, Singh S, Gauba P, et al An insight into the role of innate immune cells in breast tumor microenvironment.
Breast Cancer. 2025;32:79-100. PubMedAbstract available
TAN E, Chong J, Pua U, Tan EY, et al Local recurrence and residual tumor rates following cryoablation for small
early-stage breast cancers: systemic review and meta-analysis.
Breast Cancer. 2025;32:69-78. PubMedAbstract available
December 2024
USHIGUSA T, Hirakawa N, Kajiura Y, Yoshida A, et al Clinicopathological significance of androgen receptor expression and tumor
infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort
study.
Breast Cancer. 2024 Dec 27. doi: 10.1007/s12282-024-01662. PubMedAbstract available
LIU P, Liu D, Zhao C, Wei Y, et al Identifying subgroups of ypN1 breast cancer patients who may exempt from axillary
lymph node dissection after neoadjuvant chemotherapy: insights from a large
cohort study.
Breast Cancer. 2024 Dec 27. doi: 10.1007/s12282-024-01663. PubMedAbstract available
PARK YS, Jang SI, Shin J, Nam CM, et al Factors associated with post acute care utilization after mastectomy for breast
cancer patients.
Breast Cancer. 2024 Dec 19. doi: 10.1007/s12282-024-01659. PubMedAbstract available
KAKUMOTO A, Jamiyan T, Koyanagi A, Kuroda H, et al Prognostic impact of tumor?associated stroma in triple-negative breast cancer.
Breast Cancer. 2024 Dec 18. doi: 10.1007/s12282-024-01661. PubMedAbstract available
BATOOL Z, Kamal MA, Shen B Evidence-based advancements in breast cancer genetic counseling: a review.
Breast Cancer. 2024 Dec 17. doi: 10.1007/s12282-024-01660. PubMedAbstract available
HATTORI M Role of circulating tumor cells in breast cancer.
Breast Cancer. 2024 Dec 10. doi: 10.1007/s12282-024-01651. PubMedAbstract available
GAMBA G, Colonetti T, Uggioni MLR, Elibio LU, et al Gut microbiota and breast cancer: systematic review and meta-analysis.
Breast Cancer. 2024 Dec 9. doi: 10.1007/s12282-024-01658. PubMedAbstract available
AOYAMA Y, Ozaki Y, Kizawa R, Masuda J, et al Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for
early-stage triple-negative and estrogen receptor low, HER2-negative breast
cancer: a Japanese single-institution real-world study.
Breast Cancer. 2024 Dec 7. doi: 10.1007/s12282-024-01657. PubMedAbstract available
MORITA M, Tsunashima R, Yoshinami T, Ishida M, et al A 5-year review of genomic medicine in breast cancer: insights from C-CAT data on
3776 Japanese patients.
Breast Cancer. 2024 Dec 4. doi: 10.1007/s12282-024-01656. PubMedAbstract available
November 2024
OTANI Y, Tanaka A, Maekawa M, Pena T, et al The role of C1orf50 in breast cancer progression and prognosis.
Breast Cancer. 2024 Nov 28. doi: 10.1007/s12282-024-01653. PubMedAbstract available
KATZ D, Feldhamer I, Wolff-Sagy Y, Goldvaser H, et al Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence
score (> 25): a 10-year follow-up in a real-world cohort.
Breast Cancer. 2024 Nov 27. doi: 10.1007/s12282-024-01652. PubMedAbstract available
GUO R, Wang P The complex role of regulatory cells in breast cancer: implication for
immunopathogenesis and immunotherapy.
Breast Cancer. 2024 Nov 26. doi: 10.1007/s12282-024-01654. PubMedAbstract available
XU Q, Li X, Yuan Y, Hu Z, et al Development and validation of a predictive risk tool for VTE in women with breast
cancer under chemotherapy: a cohort study in China.
Breast Cancer. 2024 Nov 16. doi: 10.1007/s12282-024-01646. PubMedAbstract available
NASHIMOTO M, Asano Y, Matsui H, Machida Y, et al Comparison of locoregional recurrence risk among nipple-sparing mastectomy,
skin-sparing mastectomy, and simple mastectomy in patients with ductal carcinoma
in situ: a single-center study.
Breast Cancer. 2024;31:1010-1017. PubMedAbstract available
YOSHIDA R, Kaneyasu T, Ueki A, Yamauchi H, et al High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative
probands.
Breast Cancer. 2024;31:1028-1036. PubMedAbstract available
October 2024
TADA H, Miyashita M, Harada-Shoji N, Ebata A, et al Clinicopathogenomic analysis of PI3K/AKT/PTEN-altered luminal metastatic breast
cancer in Japan.
Breast Cancer. 2024 Oct 28. doi: 10.1007/s12282-024-01639. PubMedAbstract available
WANG X, Zhang X, Zhang L, Meng J, et al Clinical outcomes after post-operative radiotherapy for breast cancer patients
presenting with ipsilateral supraclavicular metastasis: considerations on the
cranial border of irradiation field.
Breast Cancer. 2024 Oct 23. doi: 10.1007/s12282-024-01644. PubMedAbstract available
TOKUNAGA E, Iwata H, Itoh M, Taira T, et al Capivasertib and fulvestrant for patients with HR-positive/HER2-negative advanced
breast cancer: analysis of the subgroup of patients from Japan in the phase 3
CAPItello-291 trial.
Breast Cancer. 2024 Oct 8. doi: 10.1007/s12282-024-01640. PubMedAbstract available
HAO J, Remis A, Zhu D, Yao Y, et al Mirror therapy for patients with breast cancer: A systematic review and
meta-analysis.
Breast Cancer. 2024 Oct 5. doi: 10.1007/s12282-024-01642. PubMedAbstract available
TAKATORI-SHIRAKAMI Y, Saito M, Yokoyama K Economic impact of screening on postdiagnosis work productivity in Japanese women
with breast cancer: a life-table modeling approach.
Breast Cancer. 2024 Oct 4. doi: 10.1007/s12282-024-01637. PubMedAbstract available
KAWAI Y, Nagayama A, Miyao K, Takeuchi M, et al A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for
resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer.
Breast Cancer. 2024 Oct 1. doi: 10.1007/s12282-024-01641. PubMedAbstract available
September 2024
KWON MR, Ko EY, Lee JE, Han BK, et al Prediction model for individualized precision surgery in breast cancer patients
with complete response on MRI and residual calcifications on mammography after
neoadjuvant chemotherapy.
Breast Cancer. 2024 Sep 30. doi: 10.1007/s12282-024-01638. PubMedAbstract available
HUANG Q, Wang J, Ning H, Liu W, et al Integrin beta1 in breast cancer: mechanisms of progression and therapy.
Breast Cancer. 2024 Sep 30. doi: 10.1007/s12282-024-01635. PubMedAbstract available
MICHAELI JC, Michaeli T, Trapani D, Albers S, et al Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits,
innovation, trials, endpoints, quality of life, value, and price.
Breast Cancer. 2024 Sep 25. doi: 10.1007/s12282-024-01634. PubMedAbstract available
ABE T, Kataoka A, Uehiro N, Yoshida N, et al Desire for pregnancy and fertility preservation in young patients with breast
cancer.
Breast Cancer. 2024 Sep 25. doi: 10.1007/s12282-024-01633. PubMedAbstract available
ENDO Y, Kotani H, Tamura N, Tanaka K, et al Utility of a breast biopsy clip and a point marker system in tailored axillary
surgery for patients with breast cancer after neoadjuvant chemotherapy.
Breast Cancer. 2024 Sep 23. doi: 10.1007/s12282-024-01630. PubMedAbstract available
NAKAYAMA T, Niikura N, Yamanaka T, Yamamoto M, et al Correction: Trastuzumab deruxtecan for the treatment of patients with
HER2-positive breast cancer with brain and/or leptomeningeal metastases: an
updated overall survival analysis using data from a multicenter retrospective
study (ROSET-BM).
Breast Cancer. 2024 Sep 20. doi: 10.1007/s12282-024-01632. PubMed
WANG RJ, Liu HY, Guo LF, Yu D, et al 21-gene recurrence score predictive of the benefit of postoperative radiotherapy
after breast-conserving surgery for elderly patients with T1N0 and luminal breast
cancer.
Breast Cancer. 2024 Sep 19. doi: 10.1007/s12282-024-01636. PubMedAbstract available
JITWATCHARAKOMOL T, Setakornnukul J, Chuthatisith S, Ratanawichitrasin A, et al Non-irradiated area of intraoperative radiotherapy with electron technique:
outcomes and pattern of failure in early-stage breast cancer from a
single-center, registry study.
Breast Cancer. 2024 Sep 10. doi: 10.1007/s12282-024-01624. PubMedAbstract available
SASADA S, Kumamaru H, Hayashi N, Kinukawa N, et al Impact of immediate breast reconstruction on perioperative therapy: insights from
a Japanese Nationwide Registry.
Breast Cancer. 2024;31:909-916. PubMedAbstract available
MIYAZAWA K, Satake T, Muto M, Tsunoda Y, et al Delayed breast reconstruction with autologous free flap after radiation therapy:
vascular complications and aesthetic outcomes.
Breast Cancer. 2024;31:798-806. PubMedAbstract available
BELLINI C, Pugliese F, Bicchierai G, Amato F, et al Contrast-enhanced mammography in the management of breast architectural
distortions and avoidance of unnecessary biopsies.
Breast Cancer. 2024;31:851-857. PubMedAbstract available
SEKI H, Sasada S, Shien T Reply to the Letter to the editor "Does axillary lymph node recurrence breast
cancer subtype information matter for prognosis estimation?".
Breast Cancer. 2024 Sep 1. doi: 10.1007/s12282-024-01629. PubMed
August 2024
CHANG YT, Hong ZJ, Tsai HH, Feng AC, et al Hub metastatic gene signature and risk score of breast cancer patients with small
tumor sizes using WGCNA.
Breast Cancer. 2024 Aug 27. doi: 10.1007/s12282-024-01627. PubMedAbstract available
GANATRA H, Tan JK, Simmons A, Bigogno CM, et al Applying whole-genome and whole-exome sequencing in breast cancer: a review of
the landscape.
Breast Cancer. 2024 Aug 27. doi: 10.1007/s12282-024-01628. PubMedAbstract available
KITADAI R, Shimoi T, Yazaki S, Okuma HS, et al Clinicopathological and prognostic features of HER2-null and HER2-low advanced
breast cancer treated with eribulin or capecitabine.
Breast Cancer. 2024 Aug 14. doi: 10.1007/s12282-024-01617. PubMedAbstract available
WATANABE M, Fujiki S, Okura Y, Toshikawa C, et al Increasing survivors of anthracycline-related cardiomyopathy with breast cancer
in trastuzumab era: thirty-one-year trends in a Japanese Community.
Breast Cancer. 2024 Aug 13. doi: 10.1007/s12282-024-01623. PubMedAbstract available
NAKAYAMA T, Niikura N, Yamanaka T, Yamamoto M, et al Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast
cancer with brain and/or leptomeningeal metastases: an updated overall survival
analysis using data from a multicenter retrospective study (ROSET-BM).
Breast Cancer. 2024 Aug 12. doi: 10.1007/s12282-024-01614. PubMedAbstract available
RAHMANI F, Ajoudanifar H, Arbab Soleimani N, Imani Fooladi AA, et al Targeted therapies in HER2-positive breast cancer with receptor-redirected
Arazyme-linker-Herceptin as a novel fusion protein.
Breast Cancer. 2024 Aug 9. doi: 10.1007/s12282-024-01625. PubMedAbstract available
RUIZ JI, Lei X, Chi-Fang W, Giordano SH, et al Survival in patients with rheumatoid arthritis and early breast cancer treated
with tumor necrosis factor inhibitors.
Breast Cancer. 2024 Aug 8. doi: 10.1007/s12282-024-01618. PubMedAbstract available
NAKAMURA M, Fujisawa T, Oyoshi H, Zhou Y, et al Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer
patients after surgery: a single center prospective observational study
(HyPORT-BC).
Breast Cancer. 2024 Aug 8. doi: 10.1007/s12282-024-01626. PubMedAbstract available
CHEN YA, Lai HW, Su HC, Loh EW, et al Efficacy and safety of adjuvant therapies in older patients with breast cancer: a
systematic review and meta-analysis of real-world data.
Breast Cancer. 2024 Aug 1. doi: 10.1007/s12282-024-01622. PubMedAbstract available
July 2024
UEZONO H, Onoe T, Shikama N, Ono Y, et al Uptake of ultra-hypofractionated radiation therapy following breast-conserving
surgery among patients with early-stage breast cancer: a multi-institutional
questionnaire survey.
Breast Cancer. 2024 Jul 24. doi: 10.1007/s12282-024-01621. PubMedAbstract available
ALTUNDAG K Does axillary lymph node recurrence breast cancer subtype information matter for
prognosis estimation?
Breast Cancer. 2024 Jul 20. doi: 10.1007/s12282-024-01620. PubMed
HU Z, Lai C, Liu H, Man J, et al Identification and validation of screening models for breast cancer with 3 serum
miRNAs in an 11,349 samples mixed cohort.
Breast Cancer. 2024 Jul 19. doi: 10.1007/s12282-024-01619. PubMedAbstract available
SHIBATA A, Tamura N, Kinowaki K, Nishikawa A, et al Development of a nomogram to predict recurrence scores obtained using Oncotype DX
in Japanese patients with breast cancer.
Breast Cancer. 2024 Jul 17. doi: 10.1007/s12282-024-01616. PubMedAbstract available
HOSONAGA M, Habano E, Arakawa H, Kaneko K, et al Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer
with TP53 pathogenic variant carriers.
Breast Cancer. 2024 Jul 17. doi: 10.1007/s12282-024-01612. PubMedAbstract available
PINELLI F, Barbani F, Defilippo B, Fundaro A, et al Quality of life in women with breast cancer undergoing neoadjuvant chemotherapy:
comparison between PICC and PICC-port.
Breast Cancer. 2024 Jul 9. doi: 10.1007/s12282-024-01608. PubMedAbstract available
NAKAMOTO S, Iwamoto T, Taira N, Kajiwara Y, et al The effect of exercise and educational programs for breast cancer patients on the
development of breast cancer-related lymphoedema: secondary endpoint from a
randomized controlled trial in the Setouchi Breast Project-10.
Breast Cancer. 2024 Jul 9. doi: 10.1007/s12282-024-01610. PubMedAbstract available
WEI JF, Li F, Lin JW, Dou ZA, et al Development and validation of a neoadjuvant chemotherapy pathological complete
remission model based on Reg IV expression in breast cancer tissues: a clinical
retrospective study.
Breast Cancer. 2024 Jul 8. doi: 10.1007/s12282-024-01609. PubMedAbstract available
LUO Y, Chen X, Lv R, Li Q, et al Breast-conserving surgery versus modified radical mastectomy in T1-2N3M0 stage
breast cancer: a propensity score matching analysis.
Breast Cancer. 2024 Jul 8. doi: 10.1007/s12282-024-01611. PubMedAbstract available
KOYAMA Y, Nakashima K, Orihara S, Tsunoda H, et al Inter- and intra-observer variability of qualitative visual breast-composition
assessment in mammography among Japanese physicians: a first multi-institutional
observer performance study in Japan.
Breast Cancer. 2024;31:671-683. PubMedAbstract available
MAITA KC, Avila FR, Torres-Guzman RA, Garcia JP, et al The usefulness of artificial intelligence in breast reconstruction: a systematic
review.
Breast Cancer. 2024;31:562-571. PubMedAbstract available
KATO S, Mori H, Saiga M, Watanabe S, et al Nipple-areolar complex malposition in breast reconstruction after nipple-sparing
mastectomy: a multi-institutional retrospective observational study in Japan.
Breast Cancer. 2024;31:649-658. PubMedAbstract available
June 2024
WANG B, Chu H, Wei S, Hsu H, et al Exploration of treatment strategies and susceptibility gene of postoperative
nausea and vomiting in breast cancer patients: a randomised controlled trial.
Breast Cancer. 2024 Jun 19. doi: 10.1007/s12282-024-01606. PubMedAbstract available
SEKI H, Ogiya A, Nagura N, Shimo A, et al Prognosis of isolated locoregional recurrence after early breast cancer with
immediate breast reconstruction surgery: a retrospective multi?institutional
study.
Breast Cancer. 2024 Jun 19. doi: 10.1007/s12282-024-01607. PubMedAbstract available
YAMASHITA T, Sohn JH, Tokunaga E, Niikura N, et al Trastuzumab deruxtecan versus treatment of physician's choice in previously
treated Asian patients with HER2-low unresectable/metastatic breast cancer:
subgroup analysis of the DESTINY-Breast04 study.
Breast Cancer. 2024 Jun 17. doi: 10.1007/s12282-024-01600. PubMedAbstract available
HUANG Y, Ke C, Cai J, Wei X, et al Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast
cancer.
Breast Cancer. 2024 Jun 15. doi: 10.1007/s12282-024-01605. PubMedAbstract available
TELLI ML, Litton JK, Beck JT, Jones JM, et al Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive,
early-stage triple-negative breast cancer: exploration of tumor BRCA mutational
status.
Breast Cancer. 2024 Jun 13. doi: 10.1007/s12282-024-01603. PubMedAbstract available
KITANO S, Tsunashima R, Kato C, Watanabe A, et al Validation of late recurrence prediction by gene expression profiles and
clinicopathological factors in estrogen receptor-positive breast cancer.
Breast Cancer. 2024 Jun 11. doi: 10.1007/s12282-024-01602. PubMedAbstract available
PURJA S, Nguyen DT, Kim E Breast cancer epigenetics: current and evolving treatment.
Breast Cancer. 2024 Jun 11. doi: 10.1007/s12282-024-01601. PubMedAbstract available
CHEN Y, Zhou Y, Chen J, Yang J, et al Exosomal lncRNA SNHG12 promotes angiogenesis and breast cancer progression.
Breast Cancer. 2024 Jun 4. doi: 10.1007/s12282-024-01574. PubMedAbstract available
May 2024
MUR-GIMENO E, Coll M, Yuguero-Ortiz A, Navarro M, et al Comparison of water- vs. land-based exercise for improving functional capacity
and quality of life in patients living with and beyond breast cancer (the
AQUA-FiT study): a randomized controlled trial.
Breast Cancer. 2024 May 30. doi: 10.1007/s12282-024-01596. PubMedAbstract available
TENG L, Du J, Yan S, Xu P, et al A novel nomogram and survival analysis for different lymph node status in breast
cancer based on the SEER database.
Breast Cancer. 2024 May 27. doi: 10.1007/s12282-024-01591. PubMedAbstract available
OKUYAMA H, Takada F, Taira N, Nakamura S, et al A randomized trial of the impact of symptom monitoring using an electronic
patient-reported outcome app on health-related quality of life in postmenopausal
breast cancer patients receiving adjuvant endocrine therapy.
Breast Cancer. 2024 May 26. doi: 10.1007/s12282-024-01592. PubMedAbstract available
KATARIA M, Gupta N, Kumar A, Bhoriwal S, et al Assessing the effectiveness of high frequency repetitive transcranial magnetic
stimulation for post-mastectomy pain in breast cancer patients: A randomized
controlled trial.
Breast Cancer. 2024 May 26. doi: 10.1007/s12282-024-01598. PubMedAbstract available
FRANCESCHI BT, Bezerra PHA, Torqueti MR Antitumor effects of co-treatment of resveratrol with antitumor drugs in ER- and
HER2-positive breast cancer cells are due to induction of apoptosis and
modulation of estrogen receptor expression.
Breast Cancer. 2024 May 23. doi: 10.1007/s12282-024-01590. PubMedAbstract available
JEZEQUEL P, Lasla H, Gouraud W, Basseville A, et al Mesenchymal-like immune-altered is the fourth robust triple-negative breast
cancer molecular subtype.
Breast Cancer. 2024 May 22. doi: 10.1007/s12282-024-01597. PubMedAbstract available
ALTUNDAG K Not all patients with premenopausal breast cancer will experience the negative
effects of tamoxifen treatment on their bone mineral density.
Breast Cancer. 2024 May 18. doi: 10.1007/s12282-024-01595. PubMed
DURAN S, Varol U, Tekir O, Soyturk AH, et al Resilience's impact on quality of life and post-traumatic growth in breast cancer
patients during treatment.
Breast Cancer. 2024 May 17. doi: 10.1007/s12282-024-01594. PubMedAbstract available
YAMAMOTO Y, Yamauchi C, Toyama T, Nagai S, et al Correction: The Japanese Breast Cancer Society Clinical Practice Guidelines for
Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements
on breast cancer treatment.
Breast Cancer. 2024 May 12. doi: 10.1007/s12282-024-01589. PubMed
BAO YQ, Yu TH, Huang W, Mao QF, et al Simultaneous integrated boost intensity-modulated radiotherapy post
breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic
outcomes in breast cancer patients.
Breast Cancer. 2024 May 5. doi: 10.1007/s12282-024-01588. PubMedAbstract available
VAN ROOIJ JAF, Bijkerk E, van der Hulst RRJW, Tuinder SMH, et al The influence of a previous implant-based breast reconstruction on postoperative
sensation of the deep inferior epigastric artery perforator flap.
Breast Cancer. 2024;31:456-466. PubMedAbstract available
NOGI H, Ogiya A, Ishitobi M, Yamauchi C, et al Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of
patients undergoing immediate breast reconstruction after mastectomy.
Breast Cancer. 2024;31:507-518. PubMedAbstract available
CH'NG ES Prognosis of primary breast salivary gland-type carcinoma: a propensity
score-matching analysis with invasive carcinoma of no special type based on the
SEER database for years 2010-2020.
Breast Cancer. 2024;31:496-506. PubMedAbstract available
TSUCHIDA Y, Niikura N, Chishima T, Mizuno M, et al Correlation between postoperative treatment selection and prognosis determined
using the Oncotype DX(R) test data: a retrospective multicenter study in Japan.
Breast Cancer. 2024;31:401-408. PubMedAbstract available
FUKUI R, Watanabe T, Morimoto K, Fujimoto Y, et al Reply to comment on 'An increase in tumor-infiltrating lymphocytes after
treatment is significantly associated with a poor response to neoadjuvant
endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers' by
Fukui et al.
Breast Cancer. 2024;31:536-538. PubMed
April 2024
SHIMOMURA A, Sagara Y, Koto R, Fujiwara M, et al Real-world data of HER2-negative early breast cancer patients treated with
anthracycline and/or taxane regimens in Japan.
Breast Cancer. 2024 Apr 29. doi: 10.1007/s12282-024-01572. PubMedAbstract available
KAWAMOTO H, Tsugawa K, Furuya Y, Sakamaki K, et al Percutaneous ultrasound-guided cryoablation for early-stage primary breast
cancer: a follow-up study in Japan.
Breast Cancer. 2024 Apr 27. doi: 10.1007/s12282-024-01584. PubMedAbstract available
LEE SJ, Cha CD, Hong H, Choi YY, et al Adverse effects of tamoxifen treatment on bone mineral density in premenopausal
patients with breast cancer: a systematic review and meta-analysis.
Breast Cancer. 2024 Apr 27. doi: 10.1007/s12282-024-01586. PubMedAbstract available
YANG PJ, Tsai EM, Hou MF, Lee YJ, et al Global untargeted and individual targeted plasma metabolomics of breast cancer
recurrence modified by hormone receptors.
Breast Cancer. 2024 Apr 23. doi: 10.1007/s12282-024-01579. PubMedAbstract available
YOSHINAMI T Perspectives for the clinical application of ctDNA analysis to breast cancer drug
therapy.
Breast Cancer. 2024 Apr 23. doi: 10.1007/s12282-024-01571. PubMedAbstract available
ALTUNDAG K Number of lines of previous chemotherapy regimen might affect the oucome of
sacituzumab govitecan in metastatic triple-negative breast cancer patients.
Breast Cancer. 2024 Apr 22. doi: 10.1007/s12282-024-01587. PubMed
SHANG Y, Wang X, Liu Y, Cheng W, et al Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within
T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a
retrospective cohort study based on SEER database.
Breast Cancer. 2024 Apr 21. doi: 10.1007/s12282-024-01583. PubMedAbstract available
NA S, Kim M, Park Y, Kwon HJ, et al Concordance of HER2 status between core needle biopsy and surgical resection
specimens of breast cancer: an analysis focusing on the HER2-low status.
Breast Cancer. 2024 Apr 21. doi: 10.1007/s12282-024-01585. PubMedAbstract available
YOSHINAMI T, Nagai SE, Hattori M, Okamura T, et al Real-world progression-free survival and overall survival of palbociclib plus
endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human
epidermal growth factor receptor 2-negative advanced breast cancer in the
first-line or seco
Breast Cancer. 2024 Apr 20. doi: 10.1007/s12282-024-01575. PubMedAbstract available
ROUSSET-JABLONSKI C, Lortal B, Lantheaume S, Arnould L, et al French national survey on breast cancer care: caregiver and patient views.
Breast Cancer. 2024 Apr 18. doi: 10.1007/s12282-024-01576. PubMedAbstract available
ZHANG HP, Jiang RY, Zhu JY, Sun KN, et al PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in
triple-negative breast cancer.
Breast Cancer. 2024 Apr 17. doi: 10.1007/s12282-024-01567. PubMedAbstract available
TOKUDA PJK, Mitsuyoshi T, Ono Y, Kishi T, et al Acute adverse events of ultra-hypofractionated whole-breast irradiation after
breast-conserving surgery for early breast cancer in Japan: an interim analysis
of the multi-institutional phase II UPBEAT study.
Breast Cancer. 2024 Apr 12. doi: 10.1007/s12282-024-01577. PubMedAbstract available
DE MOURA A, Loirat D, Vaillant S, Korbi S, et al Sacituzumab govitecan in metastatic triple-negative breast cancer patients
treated at Institut Curie Hospitals: efficacy, safety, and impact of brain
metastases.
Breast Cancer. 2024 Apr 10. doi: 10.1007/s12282-024-01565. PubMedAbstract available
SUZUKI K, Morishita S, Nakano J, Okayama T, et al Association between quality of life and mortality risk in patients with breast
cancer: a systematic review and meta-analysis.
Breast Cancer. 2024 Apr 9. doi: 10.1007/s12282-024-01581. PubMedAbstract available
WATANABE A, Tsunashima R, Kato C, Kitano S, et al Investigation of recurrence prediction ability of EndoPredict((R)) using microarray
data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and
indication expansion of EndoPredict((R)) from microarray data from fresh-frozen to
FFPE
Breast Cancer. 2024 Apr 8. doi: 10.1007/s12282-024-01573. PubMedAbstract available
YOSHIMURA M, Yamauchi C, Sanuki N, Hamamoto Y, et al The Japanese breast cancer society clinical practice guidelines for radiation
treatment of breast cancer, 2022 edition.
Breast Cancer. 2024 Apr 5. doi: 10.1007/s12282-024-01568. PubMedAbstract available
YAMAMOTO Y, Yamauchi C, Toyama T, Nagai S, et al The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast
Cancer, 2022 Edition: changes from the 2018 edition and general statements on
breast cancer treatment.
Breast Cancer. 2024 Apr 3. doi: 10.1007/s12282-024-01566. PubMedAbstract available
LIN D, Sturgeon KM, Muscat JE, Zhou S, et al Associations of pre-diagnosis physical activity with treatment tolerance and
treatment efficacy in breast cancer patients with neoadjuvant chemotherapy.
Breast Cancer. 2024 Apr 2. doi: 10.1007/s12282-024-01569. PubMedAbstract available
YE JH, Yu J, Huang MY, Mo YM, et al The correlation study between TOP2A gene expression in circulating tumor cells
and chemotherapeutic drug resistance of patients with breast cancer.
Breast Cancer. 2024 Apr 1. doi: 10.1007/s12282-024-01553. PubMedAbstract available
March 2024
OCHIYA T, Hashimoto K, Shimomura A Prospects for liquid biopsy using microRNA and extracellular vesicles in breast
cancer.
Breast Cancer. 2024 Mar 30. doi: 10.1007/s12282-024-01563. PubMedAbstract available
NARUI K, Satake T, Ishikawa T, Muto M, et al Endoscopic mastectomy followed by immediate breast reconstruction with fat
grafting for breast cancer.
Breast Cancer. 2024 Mar 21. doi: 10.1007/s12282-024-01561. PubMedAbstract available
HASHIMOTO K, Ochiya T, Shimomura A Liquid biopsy using non-coding RNAs and extracellular vesicles for breast cancer
management.
Breast Cancer. 2024 Mar 21. doi: 10.1007/s12282-024-01562. PubMedAbstract available
VO K, Ladbury C, Yoon S, Bazan J, et al Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer.
Breast Cancer. 2024 Mar 20. doi: 10.1007/s12282-024-01560. PubMedAbstract available
OHMURA H, Hanamura F, Okumura Y, Ando Y, et al Liquid biopsy for breast cancer and other solid tumors: a review of recent
advances.
Breast Cancer. 2024 Mar 16. doi: 10.1007/s12282-024-01556. PubMedAbstract available
HU X The role of the BTLA-HVEM complex in the pathogenesis of breast cancer.
Breast Cancer. 2024 Mar 14. doi: 10.1007/s12282-024-01557. PubMedAbstract available
LI G, Lin X, Wang X, Cai L, et al Enhancing radiosensitivity in triple-negative breast cancer through targeting
ELOB.
Breast Cancer. 2024 Mar 12. doi: 10.1007/s12282-024-01554. PubMedAbstract available
KANG D, Park S, Kim HJ, Lee J, et al Comprehensive Young Age Breast Cancer registry from clinical, genomics, and
patient-reported outcomes measured with 15 years follow-up: the CHARM cohort
profile.
Breast Cancer. 2024 Mar 12. doi: 10.1007/s12282-024-01559. PubMedAbstract available
KIDA K, Yamada A, Shimada K, Narui K, et al A prospective comparison study utilizing patient-reported outcomes of
taxane-related peripheral neuropathy between nab-paclitaxel and standard
paclitaxel in patients with breast cancer.
Breast Cancer. 2024 Mar 8. doi: 10.1007/s12282-024-01551. PubMedAbstract available
OBA K, Adachi M, Kobayashi T, Takaya E, et al Deep learning model to predict Ki-67 expression of breast cancer using digital
breast tomosynthesis.
Breast Cancer. 2024 Mar 7. doi: 10.1007/s12282-024-01549. PubMedAbstract available
HATTORI M, Honma N, Nagai S, Narui K, et al Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced
or metastatic breast cancer: recommendations from the Japanese Breast Cancer
Society Clinical Practice Guidelines.
Breast Cancer. 2024 Mar 4. doi: 10.1007/s12282-024-01550. PubMedAbstract available
KASAHARA M, Kanematsu S, Tanaka Y, Okazaki S, et al Clinical benefits of tomosynthesis-guided vacuum assisted breast biopsy: a
comparison with stereotactic vacuum assisted biopsy.
Breast Cancer. 2024;31:329-334. PubMedAbstract available
WU X, Gui Y, Liu J, Li S, et al Patient-reported outcomes of mesh in minimally invasive
(laparoscopic/robot-assisted) immediate subpectoral prosthesis breast
reconstruction: a retrospective study.
Breast Cancer. 2024;31:243-251. PubMedAbstract available
WONG HH, Cojocaru E, Watkins J, James S, et al Radiation-induced angiosarcoma of the breast: retrospective analysis at a
regional treatment centre.
Breast Cancer. 2024;31:272-282. PubMedAbstract available
AOYAMA Y, Hoshino E, Shimomura A, Shimizu C, et al Reliability and validity of the Japanese version of the Chemotherapy-induced
Alopecia Distress Scale.
Breast Cancer. 2024;31:234-242. PubMedAbstract available
CHEN BF, Tsai YF, Lien PJ, Lin YS, et al Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers
using a comprehensive genomic profiling assay in Taiwan.
Breast Cancer. 2024;31:217-227. PubMedAbstract available
NAKAMURA A, Ohnuki K, Takahashi H, Usami S, et al The effects of breast density on the benefits of mammograms with adjunctive
ultrasonography in breast screening.
Breast Cancer. 2024;31:228-233. PubMedAbstract available
February 2024
PARIJA M, Prakash S, Krishna BM, Dash S, et al SIRT1 mediates breast cancer development and tumorigenesis controlled by
estrogen-related receptor beta.
Breast Cancer. 2024 Feb 29. doi: 10.1007/s12282-024-01555. PubMedAbstract available